aspirin

Generic: aspirin

Labeler: marlex pharmaceuticals inc.
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name aspirin
Generic Name aspirin
Labeler marlex pharmaceuticals inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

aspirin 81 mg/1

Manufacturer
Marlex Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 10135-729
Product ID 10135-729_3ba085f8-2eeb-8958-e063-6394a90a7739
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M013
Listing Expiration 2026-12-31
Marketing Start 2021-09-01

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]
Physiologic Effect
decreased prostaglandin production [pe] decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 10135729
Hyphenated Format 10135-729

Supplemental Identifiers

RxCUI
308416
UNII
R16CO5Y76E
NUI
N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name aspirin (source: ndc)
Generic Name aspirin (source: ndc)
Application Number M013 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 81 mg/1
source: ndc
Packaging
  • 1000 TABLET in 1 BOTTLE (10135-729-10)
  • 120 TABLET in 1 BOTTLE (10135-729-62)
source: ndc

Packages (2)

10135-729-10 1000 TABLET in 1 BOTTLE (10135-729-10) 10135-729-62 120 TABLET in 1 BOTTLE (10135-729-62)

Ingredients (1)

aspirin (81 mg/1)

Linked Drug Pages (1)

Aspirin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3ba085f8-2eeb-8958-e063-6394a90a7739", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "unii": ["R16CO5Y76E"], "rxcui": ["308416"], "spl_set_id": ["cc7013ea-cf30-6f59-e053-2a95a90a1148"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Marlex Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET in 1 BOTTLE (10135-729-10)", "package_ndc": "10135-729-10", "marketing_start_date": "20250805"}, {"sample": false, "description": "120 TABLET in 1 BOTTLE (10135-729-62)", "package_ndc": "10135-729-62", "marketing_start_date": "20210901"}], "brand_name": "Aspirin", "product_id": "10135-729_3ba085f8-2eeb-8958-e063-6394a90a7739", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "10135-729", "generic_name": "Aspirin", "labeler_name": "Marlex Pharmaceuticals Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Aspirin", "active_ingredients": [{"name": "ASPIRIN", "strength": "81 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20210901", "listing_expiration_date": "20261231"}